Insights On Pharmaceutical Packaging
-
The Enhanced Version Of Ready-To-Use Vial Platform
1/13/2025
Discover a platform for aseptic manufacturing that offers pre-sterilized vials for biologics to improve efficiency and safety with automated filling systems and advanced packaging for optimized drug containment.
-
Data-Driven Methods for Ensuring Container Closure Integrity
12/18/2024
An integral component to a robust quality control program is container closure integrity testing (CCIT), which helps ensure the prevention of contamination and/or the degradation of a product.
-
A Practical Packaging Components Checklist For Emerging Biotechs
6/20/2024
A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.
-
How DFM Promotes Scalability, Repeatability, And Profitability
6/28/2024
Find out why it is critical that OEMs see and understand the benefits of taking time to build a mold or create automation more robustly to achieve long-term savings and higher annual production.
-
Providing Packing And Blinding Solutions For An Innovative Drug Start-Up
9/13/2024
Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.
-
Sachet Packaging Solutions
3/4/2025
Discover versatile, high-quality sachets for manufacturers and consumers with an ideal fill weight of 2 grams and above that is suitable for food or liquid formulas.
-
The Rising Need For Flexibility In Blister Packaging For CDMOs And Drug Manufacturers
8/1/2024
In the pharmaceutical industry, processes are subject to continuous change due to evolving requirements and regulations. Consequently, pharmaceutical companies and contract packagers often require adaptable packaging solutions, such as blister machines, to meet these dynamic needs.
-
Delivering On GLP-1 Demand: Combining Device And Supply Strategy
5/7/2024
Meeting the demand for GLP-1 treatments requires robust and efficient delivery systems. Review how innovative solutions offer customization, streamlined manufacturing, and formulation compatibility.
-
FAQs On The Revised EU GMP Annex 1: Volume 2
3/5/2025
Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.
-
Extractables And Leachables: Risk Management And Analytical Solutions
10/11/2023
Partnering with a CDMO that offers comprehensive and robust E&L studies can help facilitate a smooth product launch by ensuring minimal impact from impurities, all while mitigating risks.